lobbying_activities: 1259305

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1259305	320fb601-c9ca-4df5-98f4-a2d30f200693	Q2	CALIFORNIA LIFE SCIENCES	7758	CALIFORNIA LIFE SCIENCES	2012	second_quarter	HCR	Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Support drug and device user fee legislation. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Support HR 2182, the Generating Antibiotic Incentives Now (GAIN) Act.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		150000	0	0	2012-07-09T15:30:25.997000-04:00